Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,366 | 177 | 87.2% |
| Travel and Lodging | $963.95 | 3 | 11.4% |
| Education | $95.01 | 1 | 1.1% |
| Gift | $19.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $1,600 | 9 | $0 (2024) |
| Alcon Laboratories Inc | $1,010 | 29 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $747.46 | 14 | $0 (2021) |
| Sight Sciences, Inc. | $671.01 | 10 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $562.38 | 24 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $510.71 | 7 | $0 (2017) |
| Allergan, Inc. | $504.28 | 10 | $0 (2021) |
| CooperVision Inc. | $438.52 | 9 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $315.60 | 16 | $0 (2024) |
| Alcon Vision LLC | $314.46 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $371.06 | 14 | BIOTISSUE HOLDINGS INC. ($119.36) |
| 2023 | $2,075 | 29 | BIOTISSUE HOLDINGS, INC. ($1,481) |
| 2022 | $292.97 | 9 | Johnson & Johnson Vision Care, Inc. ($104.98) |
| 2021 | $886.04 | 24 | Sight Sciences, Inc. ($238.66) |
| 2020 | $310.60 | 13 | Sight Sciences, Inc. ($118.61) |
| 2019 | $914.44 | 20 | Sight Sciences, Inc. ($313.74) |
| 2018 | $1,724 | 34 | Alcon Laboratories Inc ($717.52) |
| 2017 | $1,870 | 39 | Valeant Pharmaceuticals North America LLC ($510.71) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Ophthalmology | ||||||
| 10/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: EYE CARE | ||||||
| 09/13/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Ophthalmology | ||||||
| 09/02/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $119.36 | General |
| 08/27/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Ophthalmology | ||||||
| 08/26/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: EYE CARE | ||||||
| 07/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Ophthalmology | ||||||
| 04/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Ophthalmology | ||||||
| 03/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Ophthalmology | ||||||
| 03/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Ophthalmology | ||||||
| 11/15/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Ophthalmology | ||||||
| 10/23/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: TEPEZZA | ||||||
| 10/18/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: Ophthalmology | ||||||
| 10/17/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Ophthalmology | ||||||
| 09/08/2023 | BIOTISSUE HOLDINGS, INC. | — | Travel and Lodging | Cash or cash equivalent | $408.97 | General |
| 09/08/2023 | BIOTISSUE HOLDINGS, INC. | — | Travel and Lodging | Cash or cash equivalent | $346.00 | General |
| 09/08/2023 | BIOTISSUE HOLDINGS, INC. | — | Travel and Lodging | Cash or cash equivalent | $208.98 | General |
| 09/05/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $26.83 | General |
| 08/09/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Ophthalmology | ||||||
| 08/07/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $155.68 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 06/29/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 435 | 533 | $58,295 | $26,394 |
| 2022 | 10 | 460 | 554 | $61,740 | $28,851 |
| 2021 | 11 | 514 | 616 | $66,800 | $35,659 |
| 2020 | 8 | 392 | 490 | $53,250 | $27,985 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 72 | 80 | $12,000 | $6,642 | 55.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 53 | 94 | $9,400 | $5,773 | 61.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 49 | $7,500 | $3,587 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 48 | $6,225 | $2,788 | 44.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 47 | 53 | $6,360 | $2,174 | 34.2% |
| 92250 | Photography of the retina | Office | 2023 | 66 | 70 | $6,300 | $1,708 | 27.1% |
| 92283 | Extended exam involving color vision testing | Office | 2023 | 35 | 35 | $2,800 | $1,335 | 47.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 37 | 51 | $3,825 | $1,277 | 33.4% |
| 92134 | Imaging of retina | Office | 2023 | 15 | 19 | $1,425 | $474.06 | 33.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 18 | 18 | $1,260 | $327.34 | 26.0% |
| 0507T | Near infrared dual imaging of tear glands with interpretation and report | Office | 2023 | 16 | 16 | $1,200 | $308.98 | 25.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 88 | 94 | $14,100 | $7,844 | 55.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 130 | $16,250 | $7,818 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 50 | $7,500 | $4,614 | 61.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 50 | 57 | $5,985 | $2,486 | 41.5% |
| 92250 | Photography of the retina | Office | 2022 | 69 | 74 | $6,660 | $1,937 | 29.1% |
| 92283 | Extended exam involving color vision testing | Office | 2022 | 32 | 33 | $2,640 | $1,255 | 47.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 39 | 44 | $3,300 | $1,129 | 34.2% |
| 92134 | Imaging of retina | Office | 2022 | 22 | 27 | $2,025 | $776.91 | 38.4% |
| 0507T | Near infrared dual imaging of tear glands with interpretation and report | Office | 2022 | 25 | 26 | $1,950 | $576.02 | 29.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 17 | 19 | $1,330 | $413.33 | 31.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 82 | 90 | $13,500 | $7,996 | 59.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 92 | $11,500 | $6,668 | 58.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 54 | 91 | $9,100 | $6,042 | 66.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 47 | $7,050 | $4,624 | 65.6% |
About Dr. John Corrow, O.D
Dr. John Corrow, O.D is a Optometrist healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720095953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Corrow, O.D has received a total of $8,444 in payments from pharmaceutical and medical device companies, with $371.06 received in 2024. These payments were reported across 182 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($7,366).
As a Medicare-enrolled provider, Corrow has provided services to 1,801 Medicare beneficiaries, totaling 2,193 services with total Medicare billing of $118,889. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Providence, RI
- Active Since 08/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1720095953
Products in Payments
- ULTRA (Device) $1,174
- DAILIES (Device) $1,172
- PROKERA (Device) $516.62
- XIIDRA (Drug) $516.07
- TearCare (Device) $432.35
- Multiple Brands Contact Lens (Device) $425.02
- RESTASIS (Drug) $324.96
- Acuvue (Device) $304.57
- Cequa (Drug) $300.77
- TearCare SmartLid (Device) $238.66
- rocklatan (Drug) $236.22
- CIRRUS HD-OCT (Device) $194.55
- TRAVATAN Z (Drug) $133.06
- OCT (Device) $113.09
- INVELTYS (Drug) $73.50
- Precision 1 (Device) $56.56
- XDEMVY (Drug) $55.75
- LUMIGAN (Drug) $49.17
- INFUSE (Device) $48.25
- P200DTx (Device) $38.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Providence
Kriti Bhagat, Od, OD
Optometrist — Payments: $249,075
Dr. Carl Corrow, O.d, O.D
Optometrist — Payments: $8,816
Dr. Scott Sylvia, Od/Mba, OD/MBA
Optometrist — Payments: $8,228
Dr. Michael Martinez, O.d, O.D
Optometrist — Payments: $3,188
Chad Waggoner, Od, OD
Optometrist — Payments: $2,959
Dr. Rickie Chin, Od, OD
Optometrist — Payments: $2,354